(4S)‐3‐[(2R,3S)‐3‐Hydr­oxy‐2‐methyl‐3‐phenyl­propion­yl]‐4‐isopropyl­oxazolidin‐2‐one

The mol­ecule of the title compound, C₁₆H₂₁NO₄, is chiral and has three asymmetric centres. The absolute configuration was not determined via diffraction measurements on the crystal, but was established from the known absolute configuration of the starting material. In the crystal structure, the mol­ecules assemble through inter­molecular hydrogen bonds into a macrostructure with helical channels.     

The absolute configuration of (2S,4S)‐ and (2R,4R)‐2‐tert‐butyl‐4‐methyl‐3‐(4‐tolyl­sulfon­yl)‐1,3‐oxazolidine‐4‐carbaldehyde

The title enanti­omorphic compounds, C₁₆H₂₃NO₄S, have been obtained in an enanti­omerically pure form by crystallization from a diastereomeric mixture either of (2S,4S)‐ and (2R,4S)‐ or of (2R,4R)‐ and (2S,4R)‐2‐tert‐butyl‐4‐methyl‐3‐(4‐tolyl­sulfon­yl)‐1,3‐oxazolidine‐4‐carbaldehyde. These mixtures were prepared by an aziridination rearrangement process starting with (S)‐ or (R)‐2‐tert‐butyl‐5‐methyl‐4H‐1,3‐dioxine. The crystal structures indicate an envelope conformation of the oxazolidine moiety for both compounds.     

(1R,2R)‐2‐(4‐Methylenecyclohex‐2‐enyl)propyl (1R,4S)‐camphanate

Esterification of a single diastereomer of 2‐(4‐methylene­cyclohex‐2‐enyl)propanol, (II), with (1R,4S)‐(+)‐camphanic acid [(1R,4S)‐4,7,7‐trimethyl‐3‐oxo‐2‐oxabicyclo[2.2.1]heptane‐1‐carboxylic acid] leads to the crystalline title compound, C₂₀H₂₈O₄. The relative configuration of the camphanate was determined by X‐ray diffraction analysis. The outcome clarifies the relative and absolute stereochemistry of the naturally occurring bisabolane sesquiterpenes β‐turmerone and β‐sesquiphellandrene, since we have converted (II) into both natural products via a stereospecific route.     

(1R,3S)‐Camphoramic acid

The title chiral compound, 3‐amino­carbonyl‐1,2,2‐tri­methyl­cyclo­pentane‐1‐carboxylic acid, C₁₀H₁₇NO₃, was prepared from (1R,3S)‐camphoric acid. The five‐membered ring adopts a conformation which is intermediate between a twist and an envelope. Elongations of the C—C bonds and contractions of the C—C—C bond angles are observed within the five‐membered ring. A ¹H NMR spectrum was recorded to assist in distinguishing the amide group from the carboxyl group.     

(1S,2R,2′S)‐ and (1S,2S,2′S)‐1‐phenyl‐2‐phenyl­thio‐2‐(tetra­hydro­pyran‐2′‐yl­thio)­ethanol diastereoisomers at 193 K

In the synthesis of 1‐phenyl‐2‐phenyl­thio‐2‐(tetra­hydro­pyran‐2‐yl­thio)­ethanol, C₁₉H₂₂O₂S₂, four diastereoisomers are formed. Two non‐centrosymmetric enantiomeric forms which crystallize in space groups P2₁2₁2₁ and Pna2₁ are presented. The former has an intramolecular hydrogen bond between the hydroxyl group and the O atom of the tetra­hydro­pyran ring. In the latter isomer, the hydroxyl group forms an intermolecular hydrogen bond to the O atom of the tetra­hydro­pyran­yl group of a neighbouring mol­ecule, joining the mol­ecules into chains in the c‐axis direction; the O?O distances are 2.962 (4) and 2.764 (3) Å, respectively. The tetra­hydro­pyran rings are in chair conformations in both isomers and the S side chain has an equatorial orientation in the former, but an axial orientation in the latter mol­ecule.     

Conformational change induced by hydration: trans‐dichloro­bis­[(1R,2R,3R,5S)‐(–)‐isopinocampheylamine]palladium(II) and trans‐dichloro­bis[(1S,2S,3S,5R)‐(+)‐isopinocampheylamine]palladium(II) hemihydrate

The title compounds, trans‐dichloro­bis[(1R,2R,3R,5S)‐(−)‐2,6,6‐trimethyl­bicyclo­[3.1.1]heptan‐3‐amine]palladium(II), [PdCl₂(C₁₀H₁₉N)₂], and trans‐dichloro­bis[(1S,2S,3S,5R)‐(+)‐2,6,6‐trimethyl­bicyclo­[3.1.1]heptan‐3‐amine]palladium(II) hemihydrate, [PdCl₂(C₁₀H₁₉N)₂]·0.5H₂O, present different arrangements of the amine ligands coordinated to Pd^II, viz. antiperiplanar in the former case and (−)anticlinal in the latter. The hemihydrate is an inclusion compound, with a Pd coordination complex and disordered water mol­ecules residing on crystallographic twofold axes. The crystal structure for the hemihydrate includes a short Pd⋯Pd separation of 3.4133 (13) Å.     

Polymeric (μ2‐nitrato‐κ2O:O′)(μ2‐nitrato‐κ2O:O)(μ4‐pyridinium‐4‐thiol­ato‐κ4S:S:S:S)­disilver(I)

The title compound, [Ag₂(NO₃)₂(C₅H₅NS)]_n, was obtained from the reaction of silver nitrate with bis(4‐pyridyl) disufide (4‐PDS) in a mixture of ethanol and water, which suggests that the di­sulfide bond of 4‐PDS can be cleaved under mild conditions. The structure of the title compound is a two‐dimensional infinite array in which the asymmetric unit contains two Ag atoms, a pyridinium‐4‐thiol­ate mol­ecule and two nitrate groups. Each pyridinium‐4‐thiol­ate mol­ecule acts as a μ₄ bridge, linking four Ag atoms, with Ag—S bond distances of 2.4870 (19), 2.5791 (19), 2.5992 (19) and 2.848 (2) Å. The Ag⋯Ag distances lie in the range 2.889 (2)–3.049 (1) Å.     

(1R,3S)‐1‐Mono­amido­camphoric acid

The title compound, (1S,3R)‐3‐carbamoyl‐2,2,3‐tri­methyl­cyclo­pentane‐1‐carboxyl­ic acid, C₁₀H₁₇NO₃, was synthesized and characterized by IR, EA, ES–MS (electrospray ionization mass spectra), ¹H NMR, ¹³C NMR and X‐ray diffraction techniques. The two independent mol­ecules form a two‐dimensional network via O—H⃛O and N—H⃛O hydrogen‐bonding interactions between their carbox­ylic acid and carbamoyl groups.     

A cyclic tetramer of [Ag(1,4,7‐trithiacyclononane)]+, cyclo‐tetrakis(μ‐1,4,7‐trithiacyclononane‐κ3S1,S4,S7:κS1)tetrasilver(I) tetrakis(trifluoromethanesulfonate) nitromethane disolvate

(1,4,7‐Tri­thia­cyclo­nonane)silver tri­fluoro­methane­sulfonate crystallizes in a tetrameric form from nitro­methane, to give the title compound, [Ag₄(C₆H₁₂S₃)₄](CF₃SO₃)₄·2CH₃NO₂. The complex cation consists of four [AgL]⁺ units (L is 1,4,7‐tri­thia­cyclo­nonane), with four Ag—S—Ag bridges forming a cyclic tetramer. The almost planar Ag₄S₄ ring takes an octagonal form.     

(1S,4R,5R,6R)‐6‐Methoxycarbonyl‐4‐pivaloyloxy‐2‐(pivaloyloxymethyl)bicyclo[3.1.0]hex‐2‐ene‐1‐carboxylic acid

The stereochemistry of the title compound, C₂₀H₂₈O₈, a key step in the preparation of analogues of mannostatins, potent inhibitors of α‐mannosidase, has been established. The carboxyl­ic acid group at C1 unexpectedly eclipses the C1—C2 bond. The cyclo­propane ring makes a dihedral angle of 109.4 (2)° with the cyclo­pentene ring.     

(3R,4S)‐3‐Phenyl‐1‐[(R)‐1‐phenyl­ethyl]‐4‐[(R)‐1‐phenylethyliminomethyl]azetidin‐2‐one

The configuration of the chiral ring atoms of the title compound, C₂₆H₂₆N₂O, obtained in an enantioselective synthesis, has been established relative to the known R configuration of the α‐methyl­benzyl moieties. The crystal packing involves a two‐dimensional network of C—H?π interactions between the aromatic rings.     

(1S,3R,8S,9S,10R)‐2,2‐Dichloro‐9,10‐epoxy‐3,7,7,10‐tetramethyltricyclo[6.4.0.01,3]dodecane and (1S,3R,8S,10R)‐2,2‐dichloro‐3,7,7,10‐tetramethyltricyclo[6.4.0.01,3]dodecan‐9‐one

The stereochemistries of the title compounds, both C₁₆H₂₄Cl₂O, have been established by X‐ray diffraction. In both structures, the seven‐membered ring adopts the same conformation, whereas the six‐membered ring shows an envelope conformation in the epoxy­do­decane structure and a boat conformation in the dodecan‐9‐one structure.     

New electron‐deficient chiral phosphines: (4R,5R)‐1,3‐bis(trifluoromethanesulfonyl)perhydro‐1,3,2‐benzodiazaphosphol‐2‐yl] substituted amines

Three chiral electron‐deficient phosphine ligands, [(4R,15R)‐,3‐bis­(tri­fluoro­methane­sulfonyl)­per­hydro‐1,3,2‐benzodiazaphosphol‐2‐yl]­diethyl­amine, C₁₂H₂₀F₆N₃O₄PS₂, (IIIa), [(4R,5R)‐1,3‐bis­(tri­fluoro­methane­sulfonyl)­per­hydro‐1,3,2‐benzodi­aza­phosphol‐2‐yl]­di­methyl­amine, C₁₀H₁₆F₆N₃O₄PS₂, (IIIb), and bis­[(4R,5R)‐1,3‐bis­(tri­fluoro­methane­sulfonyl)­per­hydro‐1,3,2‐benzodi­aza­phosphol‐2‐yl]­methyl­amine, (IV), as the chloroform solvate, C₁₇H₂₃F₁₂N₅O₈P₂S₄·0.98CHCl₃, have been prepared from (1R,2R)‐N,N′‐bis­(tri­fluoro­methane­sulfonyl)‐1,2‐cyclo­hexane­di­amine and diethyl phosphor­amido­us dichloride, dimethyl phosphoramidous dichloride or methyl imidodi­phosphorus tetrachloride. The π‐acceptor abilities of these new types of ligands have been evaluated by X‐ray determination of the P—N bond lengths; it has been found that the most promising ligand is the bis­(phosphine) (IV).     

tert‐Butyl (6S)‐4‐hydroxy‐6‐isobutyl‐2‐oxo‐1,2,5,6‐tetra­hydropyridine‐1‐carboxyl­ate and tert‐butyl (4R,6S)‐4‐hydroxy‐6‐iso­butyl‐2‐oxopiperidine‐1‐carboxyl­ate

X‐ray studies reveal that tert‐butyl (6S)‐6‐iso­butyl‐2,4‐dioxo­piperidine‐1‐carboxyl­ate occurs in the 4‐enol form, viz. tert‐butyl (6S)‐4‐hydroxy‐6‐iso­butyl‐2‐oxo‐1,2,5,6‐tetra­hydropyri­dine‐1‐carboxyl­ate, C₁₄H₂₃NO₄, when crystals are grown from a mixture of di­chloro­methane and pentane, and has an axial orientation of the iso­butyl side chain at the 6‐position of the piperidine ring. Reduction of the keto functionality leads predominantly to the corresponding β‐hydroxy­lated δ‐lactam, tert‐butyl (4R,6S)‐4‐hydroxy‐6‐iso­butyl‐2‐oxo­piperidine‐1‐car­boxyl­ate, C₁₄H₂₅NO₄, with a cis configuration of the 4‐hydroxy and 6‐iso­butyl groups. The two compounds show similar molecular packing driven by strong O—H⋯O=C hydrogen bonds, leading to infinite chains in the crystal structure.     

Di­aqua­bis­[μ‐(R,R)‐tartrato‐κ4O1,O2:O3,O4]­dinickel(II) trihydrate

In the crystal structure of the title compound, [Ni₂(C₄H₄O₆)₂(H₂O)₂]·3H₂O, two nickel cations, two tartrate anions and two water mol­ecules form the dimeric complex. Each nickel cation is in a distorted octahedral environment composed of four O atoms of two crystallographically independent tartrate anions, one water mol­ecule and one O atom of a symmetry‐equivalent tartrate anion. The asymmetric unit contains three additional water mol­ecules which are connected via hydrogen bonding.     

(3R,4aS,5R)‐3‐Hydro­xy‐5‐isopropenyl‐3,8‐di­methyl‐4,4a,5,6‐tetra­hydro‐2(3H)‐naphthalenone

In the crystal structure of C₁₅H₂₀O₂, mol­ecules are associated by intermolecular hydrogen bonds between the hydroxy function and a keto group [O?O 2.770 (2) Å], forming chains along the [100] direction in the crystal. Both six‐membered rings in the decalin unit adopt envelope conformations; one section of the mol­ecule, encompassing the extended conjugation of a C=C double bond with an enone functionality [C=C—C=O = 175.6 (2)° and C=C—C=C = 176.6 (2)°], is flat, whilst the rest of the mol­ecule is folded relative to the constrained part. The stereochemistry was determined from the R‐(–)‐carvone starting material.     

(1R,8R,11R)‐3,3,11‐Tri­methyl‐6,6‐ethyl­ene­dioxy­bi­cyclo­[6.3.0]­undecan‐2‐one and (1R,2R,8R,11R)‐3,3,11‐tri­methyl‐6,6‐ethylenedioxybicyclo[6.3.0]undecan‐2‐ol

The reduction of (1R,8R,11R)‐3,3,11‐tri­methyl‐6,6‐ethyl­ene­dioxy­bi­cyclo­[6.3.0]­undecan‐2‐one, C₁₆H₂₆O₃, (I), gave exclusively an alcohol, C₁₆H₂₈O₃, (II). The stereochemistry of the hydroxyl group in (II) was shown as R. The conformation around the eight‐membered carbocycle in (I) differs markedly from that in (II).     

The lack of C2 molecular symmetry in (1R,2R,3S,6S)‐3,6‐di­benzyl­oxycyclo­hex‐4‐ene‐1,2‐diol

The results of a single‐crystal X‐ray experiment and density functional theory calculations performed for the title compound, C₂₀H₂₂O₄, demonstrate that the lowest energy conformation of this mol­ecule does not contain C2 molecular symmetry.     

The diastereoisomers methyl 5‐(S)‐[2‐(R)/(S)‐methoxycarbonyl)‐2,3,4,5‐tetrahydropyrrol‐1‐ylcarbonyl]‐1‐(4‐methylphenyl)‐4,5‐dihydropyrazole‐3‐carboxylate

The title diastereoisomers, methyl 5‐(S)‐[2‐(S)‐methoxy­carbonyl)‐2,3,4,5‐tetra­hydro­pyrrol‐1‐yl­carbonyl]‐1‐(4‐methyl­phenyl)‐4,5‐di­hydro­pyrazole‐3‐carboxyl­ate and methyl 5‐(S)‐[2‐(R)‐methoxycarbonyl)‐2,3,4,5‐tetrahydropyrrol‐1‐ylcarbonyl]‐1‐(4‐methyl­phenyl)‐4,5‐di­hydro­pyrazole‐3‐carboxylate, both C₁₉H₂₃N₃O₅, have been studied in two crystalline forms. The first form, methyl 5‐(S)‐[2‐(S)‐methoxy­carbonyl)‐2,3,4,5‐tetrahydropyrrol‐1‐ylcarbonyl]‐1‐(4‐methylphenyl)‐4,5‐di­hydro­pyrazole‐3‐carboxyl­ate–methyl 5‐(S)‐[2‐(R)‐methoxy­carbonyl)‐2,3,4,5‐tetra­hydro­pyrrol‐1‐yl­carbonyl]‐1‐(4‐methylphenyl)‐4,5‐dihydropyrazole‐3‐carboxylate (1/1), 2(S),5(S)‐C₁₉H₂₃N₃O₅·2(R),5(S)‐C₁₉H₂₃N₃O₅, contains both S,S and S,R isomers, while the second, methyl 5‐(S)‐[2‐(S)‐methoxycarbonyl)‐2,3,4,5‐tetrahydro­pyrrol‐1‐ylcarbonyl]‐1‐(4‐methyl­phenyl)‐4,5‐di­hydro­pyrazole‐3‐carboxyl­ate, 2(S),5(S)‐C₁₉H₂₃N₃O₅, is the pure S,S isomer. The S,S isomers in the two structures show very similar geometries, the maximum difference being about 15° on one torsion angle. The differences between the S,S and S,R isomers, apart from those due to the inversion of one chiral centre, are more remarkable, and are partially due to a possible rotational disorder of the 2‐­(methoxycarbonyl)tetrahydropyrrole group.     

9(R)‐[6(R)‐Hydroxy­methyl‐1‐oxa‐4‐thia­cyclo­hexan‐2‐yl]hypoxanthine–water (4/3), a nucleoside analogue

The title compound, 9(R)‐[6(R)‐hydroxy­methyl‐1‐oxa‐4‐thia­cyclo­hexan‐2‐yl]‐1,9‐di­hydro‐6H‐purin‐6‐one–water (4/3), C₁₀H₁₂N₄O₃S·0.75H₂O, crystallizes in the triclinic space group P1 with four mol­ecules in the asymmetric unit and 0.75 waters of hydration per mol­ecule. The structure was refined to an R value of 0.072 for 3382 observed reflections. The four crystallographically independent mol­ecules are designated A, B, C and D. All four oxa­thia­ne rings adopt the chair conformation and the purine bases are in an anti orientation with respect to the sugar moieties. Molecules A and D and mol­ecules C and B are base paired by a single hydrogen bond of the type N—H?N. These base pairs are again hydrogen bonded to their translated pairs in the direction of a cell diagonal.